Oliver Lagore Vanvalin Investment Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50
| Closed | -$4.37K | – | 742 |
|
|
2024
Q1 | $4.37K | Hold |
50
| – | – | ﹤0.01% | 523 |
|
|
2023
Q4 | $4.82K | Hold |
50
| – | – | ﹤0.01% | 522 |
|
|
2023
Q3 | $4.42K | Hold |
50
| – | – | ﹤0.01% | 569 |
|
|
2023
Q2 | $4.33K | Hold |
50
| – | – | ﹤0.01% | 579 |
|
|
2023
Q1 | $4.86K | Hold |
50
| – | – | ﹤0.01% | 486 |
|
|
2022
Q4 | $5.18K | Hold |
50
| – | – | ﹤0.01% | 462 |
|
|
2022
Q3 | $4K | Sell |
50
-94
| -65% | -$7.52K | ﹤0.01% | 446 |
|
|
2022
Q2 | $12K | Hold |
144
| – | – | 0.01% | 318 |
|
|
2022
Q1 | $11K | Buy |
+144
| New | +$11K | 0.01% | 315 |
|